Insurance-backed capital protection has transformed litigation funding from a binary bet into a structured, credit-like asset. The protection comes at a cost — but for many institutional investors, it is the price of entry.
Litigation funding has long attracted interest from sophisticated investors seeking returns uncorrelated with equity and credit markets. Yet for many institutional mandates — pension funds, endowments, local authorities, and family offices — the asset class has remained out of reach. The reason is structural: a funded claim either succeeds or it does not. If it fails, the capital is lost in full. That binary risk profile sits uncomfortably alongside fiduciary duties to preserve capital, and it has historically confined litigation finance to a narrow band of specialist and high-risk-tolerant allocators. The emergence of insurance-backed capital protection changes this calculus materially.
Protection does not eliminate the cost of risk — it redistributes it. For many institutional committees, that redistribution is the condition precedent to making the asset class investible at all.
The Problem: Binary Risk and the Institutional Barrier
In a conventional litigation funding arrangement, the funder advances capital to cover legal costs — counsel fees, disbursements, expert evidence — in exchange for a share of any financial recovery. If the claim succeeds and a settlement or judgment is obtained, the funder receives its capital back plus a contractual return, typically expressed as a multiple on invested capital (MOIC) or an internal rate of return (IRR). If the claim fails, the funder recovers nothing. In jurisdictions such as England and Wales, where the “loser pays” principle applies, the funder may also bear the defendant’s legal costs. The downside is absolute.
This all-or-nothing profile is problematic for institutional capital. Investment committees operating under fiduciary frameworks — whether under the Trustee Act 2000, charity law, or comparable obligations — are required to consider capital preservation alongside return generation. A funding arrangement that carries a meaningful probability of total capital loss, with no intermediate outcome, does not map cleanly onto those obligations. The asset class has consequently remained the preserve of specialist hedge funds, family offices with high risk tolerance, and dedicated litigation finance vehicles. For the broader universe of institutional allocators, the binary nature of the risk has been a structural veto.
The Solution: How Capital Protection Works
The structural response to binary risk is the “credit wrap” — a combination of specialist insurance products that place a floor under the funded investment. Rather than accepting the full range of outcomes from zero to full recovery, the investor’s downside is bounded by the terms of the insurance policy. The investment begins to resemble secured private credit rather than an equity-like punt on litigation outcomes. Two insurance products form the core of this structure. Capital Protection Insurance (CPI) covers some or all of the deployed capital with a Tier-1 insurer. If the financial return from the claim falls below a defined threshold — including in the event of outright failure — the insurer reimburses the funder up to the limit of indemnity. The policy may also cover transaction costs and the premium itself. After-the-Event (ATE) insurance addresses the separate but related exposure to adverse costs. In England and Wales, a losing claimant is ordinarily ordered to pay the defendant’s legal costs. ATE covers that liability, along with the funder’s own disbursements. Together, CPI and ATE transform the risk profile of the investment from binary to bounded.
Key points to highlight:
— Capital Protection Insurance (CPI): secures the principal against loss up to the limit of indemnity, issued by a Tier-1 insurer. The policy may extend to cover transaction costs and the premium itself.
— After-the-Event (ATE) Insurance: covers adverse costs exposure and funded disbursements if the claim fails, addressing England and Wales’ “loser pays” rule.
— Asset-backed security: the investment is secured against the legal claim (the “chose in action”) and the associated insurance policies, with a formal funding agreement establishing a waterfall of payments on recovery.
— Independent underwriting validation: insurers conduct rigorous due diligence before agreeing to provide cover, giving investors a secondary layer of independent case assessment beyond the funder’s own analysis.
The Cost of Protection: Impact on IRR and MOIC
Capital protection is not free, and the cost structure is important to understand. Insurance premiums typically take two forms. An initial premium is paid at the outset and forms part of the capital deployed into the transaction. Because this premium does not itself generate a litigation return, it reduces the proportion of capital that is working to generate MOIC. Where costs are drawn down progressively over the life of a claim, the timing of premium payments can also lengthen the effective investment period, compressing the IRR relative to a structure without insurance.
A deferred contingent premium compounds this effect on the upside. This element of the premium — often calculated as a percentage of the indemnity limit or the transaction “carry” — is payable only upon a successful outcome, meaning the insurer participates alongside the investor in the recovery waterfall. Depending on its seniority, this payment ranks ahead of or alongside the investor’s return, reducing both MOIC and IRR on a successful outcome. The protected structure will therefore always produce a lower headline return than an equivalent unprotected position — that is the arithmetic of the trade-off. A subsequent note will examine the risk-adjusted comparison in detail, modelling protected and unprotected returns across a range of outcome scenarios.
Conclusion
Capital protection does not eliminate the cost of risk — it transfers and redistributes it. The insurance premium is the price of converting an all-or-nothing proposition into a bounded, asset-backed instrument. That conversion reduces headline MOIC and IRR, and investors should model those costs carefully. For many institutional mandates, however, the trade-off is straightforward: without protection, the allocation cannot be made at all. With it, litigation finance becomes eligible for consideration alongside other alternative credit strategies offering uncorrelated, potentially attractive risk-adjusted returns. A separate note will examine the numbers in detail.
ABOUT THE AUTHOR
This article has been prepared by the research and structuring team at Ashdown Litigation Partners. ALP specialises in identifying, structuring, and facilitating capital-protected litigation finance opportunities for institutional and professional investors.
DISCLAIMER
This article has been prepared by Ashdown Litigation Partners Ltd for general information and marketing purposes only. It does not constitute legal, financial, or investment advice and should not be relied upon as such. Ashdown Litigation Partners Ltd is a non-regulated commercial introducer and facilitator; it does not carry on regulated activities and is not authorised or regulated by the Financial Conduct Authority. Nothing in this article constitutes a financial promotion or an invitation to invest. Ashdown Litigation Partners Ltd is registered in England & Wales, No. 16015628. Registered office: 71 St James’s Drive, London SW17 7RW.
